Qlaira: novel multiphasic oral contraceptive taken continuously

Steve Chaplin, Diana Mansour
In: Prescriber · 2009 · vol. 20(20) , pp. 32–35 · doi:10.1002/psb.563 · W2008115011
article OA: bronze CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-11 ⓘ

Qlaira, a continuous multiphasic oral contraceptive, combines estradiol valerate and dienogest in four active formulations and two inert tablets, demonstrating efficacy and acceptable adverse effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Qlaira is a new multiphasic COC that is taken continuously and comprises four combinations of estradiol valerate and the progestogen dienogest, plus two inert tablets. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy, and adverse effects and Dr Mansour discusses its place in contraception. Copyright © 2009 Wiley Interface Ltd

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (2)

Source provenance

openalex
last seen: 2026-05-10T10:51:01.847503+00:00
License: CC0 · commercial use OK